Genetic test could let young women avoid breast cancer chemo
A trial tests whether women aged 35 to 54 can safely skip chemotherapy. A $3500 genetic test predicts their cancer recurrence risk.
Reported by Newcastle Herald
ShareWhy it matters
Chemotherapy side effects can last years or decades. Avoiding unnecessary treatment could protect quality of life and work capacity for tens of thousands of Australian women.
In Australia. If approved for funding, this test could become available to Australian women within months, potentially changing treatment for thousands diagnosed with hormone receptor-positive breast cancer each year.
Key facts
- $3500
- Test cost
- 35 to 54 years
- Age group in trial
- About 20% of all cases
- Young women with breast cancer
- A new trial aims to help young women with common breast cancer avoid chemo side effects.
- Breast Cancer Trials, based in Newcastle, is recruiting women through Lake Macquarie Private Hospital and other centres.
- The Optima study uses a genetic test to check how active cancer cells are.
- The test shows if they will return without treatment.
- If the test shows low risk, women can use hormone drugs instead of chemo.
- The test costs $3500 and is not yet funded by the Australian health system.
- But the company is asking for government approval.
- Young women with breast cancer tend to do worse than older women.
- Doctors often give them chemo as a precaution, even when it may not help.
- This trial could save thousands from chemo's long-term side effects like tiredness, memory loss, and nerve damage.


